Trials / Completed
CompletedNCT02022670
Sodium Nitrite to Treat Arterial Aging
Clinical Translation of Nitrite Therapy to Treat Arterial Aging in Humans
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- University of Colorado, Boulder · Academic / Other
- Sex
- All
- Age
- 50 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
The proposed research will determine the effectiveness of nitrite, a naturally occurring compound in the body, for improving the health and function of arteries in middle-aged and older adults. The study also will provide insight into how sodium nitrite therapy improves artery health by determining the physiological mechanisms (biological reasons) involved. Overall, the proposed research will provide important new scientific evidence on the effectiveness of sodium nitrite for decreasing the risk of developing cardiovascular diseases with aging.
Detailed description
The improvement in blood vessel function and stiffness will be determined over a 10 week period. Subjects will be randomly assigned to either placebo (0 mg/day), low dose (80 mg/day) or high dose (160 mg/day) sodium nitrite. Main outcome measures will be performed at baseline and week 10.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Sugar pill manufactured to mimic sodium nitrite capsules |
| DRUG | Sodium Nitrite | 80 mg/d or 160 mg/d |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2013-12-30
- Last updated
- 2015-07-15
- Results posted
- 2015-06-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02022670. Inclusion in this directory is not an endorsement.